+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GMP-grade mRNA Production Market - Global Forecast 2026-2032- Product Image
GMP-grade mRNA Production Market - Global Forecast 2026-2032- Product Image
Sale

GMP-grade mRNA Production Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6135748
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The GMP-grade mRNA Production Market is projected to reach USD 2.74 Billion in 2026. It is expected to continue growing at a CAGR of 21.63%, reaching USD 8.88 Billion by 2032.

GMP-Grade mRNA Production: Executive Overview

GMP-grade mRNA production is the controlled manufacture of messenger RNA for clinical and commercial use under good manufacturing practice requirements. The field depends on reproducible template design, enzymatic transcription, purification, formulation, aseptic processing, analytical characterization, and validated quality systems. Its strategic importance is expanding beyond vaccines into therapeutic proteins, oncology, rare diseases, and personalized medicine, while regulatory expectations increasingly emphasize product consistency, process control, traceability, and supply continuity.

Manufacturing Shifts Reshaping GMP-Grade mRNA

The production landscape is moving from campaign-based, specialized manufacturing toward more standardized and flexible platforms. Key shifts include intensified in vitro transcription, improved impurity removal, modular single-use processing, closed-system operations, and greater use of automation for batch records and process monitoring. Developers are also emphasizing design-for-manufacturing earlier in development, enabling smoother technology transfer and reducing changes between clinical phases. These shifts make analytical comparability, raw-material qualification, and scalable fill-finish capabilities central to development strategy.

How Artificial Intelligence Is Changing mRNA Production

Artificial intelligence can support mRNA production by accelerating sequence and codon optimization, identifying formulation candidates, and detecting relationships across process and quality data. Machine-learning tools may also help predict yield, impurity profiles, stability, and process deviations, provided they are trained on representative datasets and validated for intended use. In regulated environments, AI adoption requires explainability, data integrity controls, model governance, cybersecurity, and documented human oversight. Its most practical near-term role is decision support for development, process monitoring, and quality investigations rather than unsupervised release decisions.

Regional Insights Across the Global Production Network

North America combines mature biopharmaceutical infrastructure, advanced regulatory capabilities, and strong demand for rapid clinical translation. Europe benefits from established GMP expertise and coordinated scientific standards, although cross-border logistics and capacity allocation remain important considerations. Asia-Pacific is strengthening domestic manufacturing, analytical capabilities, and regional supply resilience, with Australia, China, India, Japan, and South Korea representing distinct development and production environments. Latin America is expanding biopharmaceutical capabilities while continuing to address technology access and specialized workforce needs. The Middle East is pursuing life-sciences diversification and local resilience, whereas Africa remains focused on building foundational manufacturing, quality, and technology-transfer capacity.

Strategic Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies offer a developing regional platform for pharmaceutical manufacturing, with priorities centered on workforce development, regulatory alignment, and dependable cold-chain infrastructure. BRICS members reflect varied levels of domestic capability and can support broader technology-transfer and supply-diversification objectives, although standards and infrastructure differ materially. The European Union benefits from integrated regulatory and industrial frameworks, while the G7 provides deep scientific, financial, and quality-system capabilities. GCC countries are investing in healthcare and industrial diversification, creating opportunities for localized production and regional distribution. NATO members collectively represent substantial biomedical and logistics capacity, but collaboration on GMP-grade mRNA remains primarily shaped by national health, industrial, and regulatory policies.

Country-Level Production and Capability Considerations

The United States and Canada offer strong translational ecosystems, specialized talent, and sophisticated regulatory infrastructure. Germany, France, Italy, Spain, and the United Kingdom combine established biopharmaceutical capabilities with advanced clinical and quality networks, while the European Union context supports cross-border coordination. China, Japan, and South Korea maintain substantial scientific and manufacturing depth, with continued emphasis on domestic resilience and advanced therapeutics. India is strengthening large-scale pharmaceutical and process-development capabilities. Australia supports high-quality research and clinical translation. Brazil and Mexico are important Latin American anchors for regional access and manufacturing development. Russia retains scientific and pharmaceutical assets, though international supply, collaboration, and regulatory conditions can affect operating continuity.

Actions for Leaders Building Reliable mRNA Manufacturing

Leaders should build a platform-based operating model that links sequence design, process development, analytics, formulation, fill-finish, and quality release from the outset. They should qualify multiple critical raw-material sources, document robust technology-transfer packages, and establish contingency plans for specialized equipment, enzymes, lipids, and sterile operations. Investment in advanced analytics, automation, and data integrity should be paired with clear validation and governance. Regional partnerships can strengthen workforce development and supply resilience, while early regulatory engagement can clarify expectations for comparability, novel excipients, process changes, and AI-enabled tools. Finally, organizations should use risk-based capacity planning rather than relying on a single manufacturing pathway.

Research Methodology for the GMP-Grade mRNA Assessment

This executive summary uses a qualitative synthesis of the supplied market scope, established GMP principles, biopharmaceutical manufacturing practices, regulatory considerations, and publicly recognized regional capability patterns. The analysis organizes findings across production technologies, quality systems, supply-chain requirements, digitalization, geography, and institutional groupings. It intentionally excludes market estimates, market shares, forecasts, and company-specific claims. Regional, group, and country observations are framed as strategic context and should be validated against current regulatory guidance, facility-level capabilities, and project-specific technical data before investment or operational decisions.

Conclusion: Resilience and Control Define GMP-Grade mRNA Success

GMP-grade mRNA production is becoming a platform discipline in which product quality depends on the coordinated control of design, materials, process parameters, analytics, formulation, aseptic handling, and data systems. Regional capabilities are uneven but increasingly interconnected, making supply resilience and technology transfer as important as scientific performance. Organizations that standardize development, strengthen quality-by-design practices, adopt AI with appropriate governance, and diversify critical inputs will be better positioned to advance mRNA programs reliably across clinical and commercial requirements.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. GMP-grade mRNA Production Market, by mRNA Type
7.1. Introduction
7.2. Conventional mRNA
7.2.1. Nucleoside Modified
7.2.2. Unmodified
7.3. Modified mRNA
7.4. Self Amplifying mRNA
7.4.1. Live Virus Based
7.4.2. Non Viral
8. GMP-grade mRNA Production Market, by Delivery System
8.1. Introduction
8.2. Lipid Nanoparticle
8.3. Peptide Based
8.4. Polymer Based
9. GMP-grade mRNA Production Market, by Production Scale
9.1. Introduction
9.2. Clinical Scale
9.2.1. Phase I
9.2.2. Phase II
9.2.3. Phase III
9.3. Commercial Scale
9.4. Pilot Scale
10. GMP-grade mRNA Production Market, by Application
10.1. Introduction
10.2. Therapeutics
10.2.1. Gene Editing
10.2.2. Protein Replacement Therapy
10.2.3. Regenerative Medicine
10.3. Vaccines
10.3.1. Cancer Vaccines
10.3.2. Infectious Disease Vaccines
11. GMP-grade mRNA Production Market, by End User
11.1. Introduction
11.2. Academic and Research Institutes
11.3. Contract Manufacturing Organization
11.4. Pharmaceutical Biotechnology Companies
12. GMP-grade mRNA Production Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. GMP-grade mRNA Production Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. GMP-grade mRNA Production Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AGC Biologics, Inc.
16.2. Aldevron, LLC
16.3. Anemocyte, Inc.
16.4. ARCALIS Co., Ltd.
16.5. BioNTech SE
16.6. Catalent, Inc.
16.7. CordenPharma International Corp.
16.8. CureVac AG
16.9. eTheRNA immunotherapies NV
16.10. GenScript Biotech Corporation
16.11. Lonza Group AG
16.12. Merck KGaA
16.13. Moderna, Inc.
16.14. Porton Advanced Solutions, LLC
16.15. Samsung Biologics Co., Ltd.
16.16. ST Pharm Co., Ltd.
16.17. Thermo Fisher Scientific Inc.
16.18. TriLink BioTechnologies, LLC
16.19. Vernal Biosciences, Inc.
16.20. WuXi Biologics Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global GMP-grade mRNA Production Market, Years Considered for the Study
FIGURE 2. Global GMP-grade mRNA Production Market, Research Design
FIGURE 3. Global GMP-grade mRNA Production Market, Research Framework
FIGURE 4. Global GMP-grade mRNA Production Market, Data Triangulation
FIGURE 5. Global GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
FIGURE 6. Global GMP-grade mRNA Production Market Size, by mRNA Type, 2025 vs 2032 (%)
FIGURE 7. Global GMP-grade mRNA Production Market Size, by mRNA Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global GMP-grade mRNA Production Market Size, by Delivery System, 2025 vs 2032 (%)
FIGURE 9. Global GMP-grade mRNA Production Market Size, by Delivery System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global GMP-grade mRNA Production Market Size, by Production Scale, 2025 vs 2032 (%)
FIGURE 11. Global GMP-grade mRNA Production Market Size, by Production Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global GMP-grade mRNA Production Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global GMP-grade mRNA Production Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global GMP-grade mRNA Production Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global GMP-grade mRNA Production Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global GMP-grade mRNA Production Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global GMP-grade mRNA Production Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global GMP-grade mRNA Production Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global GMP-grade mRNA Production Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global GMP-grade mRNA Production Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global GMP-grade mRNA Production Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global GMP-grade mRNA Production Market Segmentation & Coverage
TABLE 2. Global GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 3. Global GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 4. Global Conventional mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Conventional mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Conventional mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nucleoside Modified Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nucleoside Modified Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nucleoside Modified Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Unmodified Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Unmodified Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Unmodified Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Modified mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Modified mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Modified mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Self Amplifying mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Self Amplifying mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Self Amplifying mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Live Virus Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Live Virus Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Live Virus Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Non Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Non Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Non Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 26. Global Lipid Nanoparticle Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Lipid Nanoparticle Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Lipid Nanoparticle Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Peptide Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Peptide Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Peptide Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Polymer Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Polymer Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Polymer Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 36. Global Clinical Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinical Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinical Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Phase I Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Phase I Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Phase I Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Phase II Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Phase II Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Phase II Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Phase III Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Phase III Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Phase III Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Commercial Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Commercial Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Commercial Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Pilot Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Pilot Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Pilot Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 55. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Gene Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Protein Replacement Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Protein Replacement Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Protein Replacement Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Regenerative Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Regenerative Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Regenerative Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Cancer Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Cancer Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Cancer Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Infectious Disease Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Infectious Disease Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Infectious Disease Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Global Academic and Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Academic and Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Academic and Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Contract Manufacturing Organization Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Contract Manufacturing Organization Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Contract Manufacturing Organization Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Pharmaceutical Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Pharmaceutical Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Pharmaceutical Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. North America GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 100. North America GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 101. North America GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 102. North America GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 103. North America GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 104. North America GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 105. North America GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. North America GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 107. North America GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 108. North America GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Latin America GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Latin America GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 111. Latin America GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 112. Latin America GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 113. Latin America GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 114. Latin America GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 115. Latin America GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 116. Latin America GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Latin America GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 118. Latin America GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 119. Latin America GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Europe GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Europe GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 122. Europe GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 123. Europe GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 124. Europe GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 125. Europe GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 126. Europe GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 127. Europe GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Europe GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 129. Europe GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 130. Europe GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Middle East GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Middle East GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 133. Middle East GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 134. Middle East GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 135. Middle East GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 136. Middle East GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 137. Middle East GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 138. Middle East GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Middle East GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 140. Middle East GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 141. Middle East GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Africa GMP-grade mRNA Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Africa GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 144. Africa GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 145. Africa GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 146. Africa GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 147. Africa GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 148. Africa GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 149. Africa GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Africa GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 151. Africa GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 152. Africa GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Global GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. ASEAN GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. ASEAN GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 156. ASEAN GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 157. ASEAN GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 158. ASEAN GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 159. ASEAN GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 160. ASEAN GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 161. ASEAN GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. ASEAN GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 163. ASEAN GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 164. ASEAN GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. GCC GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. GCC GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 167. GCC GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 168. GCC GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 169. GCC GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 170. GCC GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 171. GCC GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 172. GCC GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. GCC GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 174. GCC GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 175. GCC GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. European Union GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. European Union GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 178. European Union GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 179. European Union GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 180. European Union GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 181. European Union GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 182. European Union GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 183. European Union GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. European Union GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 185. European Union GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 186. European Union GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. BRICS GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. BRICS GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 189. BRICS GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 190. BRICS GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 191. BRICS GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 192. BRICS GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 193. BRICS GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 194. BRICS GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. BRICS GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 196. BRICS GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 197. BRICS GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. G7 GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. G7 GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 200. G7 GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 201. G7 GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 202. G7 GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 203. G7 GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 204. G7 GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 205. G7 GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. G7 GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 207. G7 GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 208. G7 GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. NATO GMP-grade mRNA Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. NATO GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 211. NATO GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 212. NATO GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 213. NATO GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 214. NATO GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 215. NATO GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 216. NATO GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. NATO GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 218. NATO GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 219. NATO GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Global GMP-grade mRNA Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. United States GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 222. United States GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 223. United States GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 224. United States GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 225. United States GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 226. United States GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 227. United States GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 228. United States GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. United States GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 230. United States GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 231. United States GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Canada GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 233. Canada GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 234. Canada GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 235. Canada GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 236. Canada GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 237. Canada GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 238. Canada GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 239. Canada GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Canada GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 241. Canada GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 242. Canada GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Mexico GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 244. Mexico GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 245. Mexico GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 246. Mexico GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 247. Mexico GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 248. Mexico GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 249. Mexico GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 250. Mexico GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Mexico GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 252. Mexico GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 253. Mexico GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Brazil GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 255. Brazil GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 256. Brazil GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 257. Brazil GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 258. Brazil GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 259. Brazil GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 260. Brazil GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 261. Brazil GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Brazil GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 263. Brazil GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 264. Brazil GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. United Kingdom GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 266. United Kingdom GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 267. United Kingdom GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 268. United Kingdom GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 269. United Kingdom GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 270. United Kingdom GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 271. United Kingdom GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 272. United Kingdom GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. United Kingdom GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 274. United Kingdom GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 275. United Kingdom GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Germany GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 277. Germany GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 278. Germany GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 279. Germany GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 280. Germany GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 281. Germany GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 282. Germany GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 283. Germany GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. Germany GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 285. Germany GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 286. Germany GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. France GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 288. France GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 289. France GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 290. France GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 291. France GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 292. France GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 293. France GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 294. France GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. France GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 296. France GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 297. France GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Russia GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 299. Russia GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 300. Russia GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 301. Russia GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 302. Russia GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 303. Russia GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 304. Russia GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 305. Russia GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. Russia GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 307. Russia GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 308. Russia GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Italy GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 310. Italy GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 311. Italy GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 312. Italy GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 313. Italy GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 314. Italy GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 315. Italy GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 316. Italy GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Italy GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 318. Italy GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 319. Italy GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Spain GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 321. Spain GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 322. Spain GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 323. Spain GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 324. Spain GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 325. Spain GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 326. Spain GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 327. Spain GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. Spain GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 329. Spain GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 330. Spain GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. China GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 332. China GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 333. China GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032 (USD Million)
TABLE 334. China GMP-grade mRNA Production Market Size, by Self Amplifying mRNA, 2017-2032 (USD Million)
TABLE 335. China GMP-grade mRNA Production Market Size, by Delivery System, 2017-2032 (USD Million)
TABLE 336. China GMP-grade mRNA Production Market Size, by Production Scale, 2017-2032 (USD Million)
TABLE 337. China GMP-grade mRNA Production Market Size, by Clinical Scale, 2017-2032 (USD Million)
TABLE 338. China GMP-grade mRNA Production Market Size, by Application, 2017-2032 (USD Million)
TABLE 339. China GMP-grade mRNA Production Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 340. China GMP-grade mRNA Production Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 341. China GMP-grade mRNA Production Market Size, by End User, 2017-2032 (USD Million)
TABLE 342. India GMP-grade mRNA Production Market Size, 2017-2032 (USD Million)
TABLE 343. India GMP-grade mRNA Production Market Size, by mRNA Type, 2017-2032 (USD Million)
TABLE 344. India GMP-grade mRNA Production Market Size, by Conventional mRNA, 2017-2032

Companies Mentioned

  • AGC Biologics, Inc.
  • Aldevron, LLC
  • Anemocyte, Inc.
  • ARCALIS Co., Ltd.
  • BioNTech SE
  • Catalent, Inc.
  • CordenPharma International Corp.
  • CureVac AG
  • eTheRNA immunotherapies NV
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Merck KGaA
  • Moderna, Inc.
  • Porton Advanced Solutions, LLC
  • Samsung Biologics Co., Ltd.
  • ST Pharm Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, LLC
  • Vernal Biosciences, Inc.
  • WuXi Biologics Inc.

Related Topics

Related Reports

GMP-grade Protein Production Services Market - Global Forecast 2026-2032 - Product Image

GMP-grade Protein Production Services Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
GMP Protein E Coli Contract Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, Product Type, Scale, End User - Product Image

GMP Protein E Coli Contract Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, Product Type, Scale, End User

  • Report
  • 160 Pages
  • Global
From
GMP Testing Service Market Size, Share, Trends and Forecast by Service Type, End User, and Region, 2026-2034 - Product Image

GMP Testing Service Market Size, Share, Trends and Forecast by Service Type, End User, and Region, 2026-2034

  • Report
  • 147 Pages
  • Global
From
GMP Testing Service Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, End User - Product Image

GMP Testing Service Market Outlook 2026-2034: Market Share, and Growth Analysis by Service Type, End User

  • Report
  • 160 Pages
  • Global
From
Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Report 2026 - Product Image

Good Manufacturing Practice (GMP) Services for Cell and Gene Therapy Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.